Vimarsana
Biggest News Aggregation in the World

Page 10 - Eric Schadt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eric Schadt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eric Schadt Today - Breaking & Trending Today

'A validation of mission and strategy': The pandemic hasn't stopped Annie Lamont's Oak HC/FT from making major investments - Vimarsana News

'A validation of mission and strategy': The pandemic hasn't stopped Annie Lamont's Oak HC/FT from making major investments

Skip to main content Currently Reading 'A validation of mission and strategy': The pandemic hasn't stopped Annie Lamont's Oak HC/FT from making major investments FacebookTwitterEmail 1of8 Oak HC/FT co-founders and managing partners Andrew Adams, left, Patricia Kemp, center, and Annie Lamont pose outside the Oak HC/FT office at Pickwick Plaza in Greenwich, Conn., on Monday, March 8, 2021. The Greenwich-based venture capital firm invests in early to growth-stage health care and financial technology companies.Tyler Sizemore / Hearst Connecticut MediaShow MoreShow Less 2of8 Oak HC/FT co-founders ...

Genomics firms taking advantage of SPACs trend to go public faster - Vimarsana News

Genomics firms taking advantage of SPACs trend to go public faster

Genomics firms taking advantage of SPACs trend to go public faster Christie Rizk, Genomeweb Print Special-purpose acquisition companies (SPACs), once considered the province of scam artists and shady dealers, are the latest trend to hit the public markets and the scientific world as companies seek to go public more quickly and avoid some of the disadvantages of a traditional initial public offering of stock. The trend has been pronounced in the life sciences genomic tools and diagnostics industries, where initial public offerings aren't as plentiful as some other markets, like biopharma. In ...

'A great outcome': Sema4, other Connecticut biotech companies growing amid pandemic - Vimarsana News

'A great outcome': Sema4, other Connecticut biotech companies growing amid pandemic

Stamford firm joins CT biotech companies growing amid pandemic FacebookTwitterEmailLinkedInRedditPinterest Photo: Matthew Brown / Hearst Connecticut Media About four years ago, a nascent health care information firm was spun out of the Mount Sinai Health System into a new company. Today, that business is worth approximately $2 billion and about to become a publicly traded enterprise. The rise of the Stamford-headquartered Sema4 attests to the potential of Connecticut’s biotechnology sector. Powered by large-scale investment, Sema4 and other companies in the industry are growing quickly and ...

Industry framework proposes self-regulation of consumer data use, Sema4 announces SPAC merger and more digital health news briefs - Vimarsana News

Industry framework proposes self-regulation of consumer data use, Sema4 announces SPAC merger and more digital health news briefs

Share A call for independent policing of non-HIPAA health data. The Center for Democracy & Technology, a nonprofit organization focused on tech policy and architecture, and the eHealth Initiative & Foundation, a coalition of industry and academic stakeholders, yesterday released a framework proposal calling for self-regulation of consumer data use by health devices and products that don't legally require HIPAA compliance. Under the framework, companies making these products would agree to a new set of standards that rely less on simply providing consumers with notice and consent, and in...

'The right scale of fuel': Stamford-based Sema4 eyes more growth by going public - Vimarsana News

'The right scale of fuel': Stamford-based Sema4 eyes more growth by going public

'The right scale of fuel': Stamford-based Sema4 eyes more growth by going public FacebookTwitterEmail State Rep. Matt Blumenthal, at left, and Sen. Chris Murphy, at center, tour Sema4's laboratory at 62 Southfield Ave., in Stamford, Conn., on Sept. 18, 2020.Matthew Brown / Hearst Connecticut Media STAMFORD — Health care information provider Sema4 announced Wednesday that it would become a publicly traded company, an ambitious plan intended to catalyze further growth for one of the fastest-expanding firms in Connecticut. In a move that values the company at approximately $2 billion, Stamford...